Muscle health in ankylosing spondylitis: effects of disease duration, inflammation, education level, and spinal mobility on skeletal muscle atrophy

Background: Ankylosing spondylitis (AS) is a progressive chronic disease that primarily affects the axial skeleton, leading to significant musculoskeletal impairment. This condition may extend its inflammatory impact to peripheral muscles, potentially resulting in muscle wasting. Objectives: The stu...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiawen Hu, Yiwen Wang, Zhimeng Yu, Yinan Zhang, Xiaojian Ji, Lulu Zeng, Jiaxin Zhang, Shiwei Yang, Kunpeng Li, Jian Zhu, Jianglin Zhang, Yinghua Liu, Feng Huang
Format: Article
Language:English
Published: SAGE Publishing 2025-05-01
Series:Therapeutic Advances in Musculoskeletal Disease
Online Access:https://doi.org/10.1177/1759720X251335591
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850033900606193664
author Jiawen Hu
Yiwen Wang
Zhimeng Yu
Yinan Zhang
Xiaojian Ji
Lulu Zeng
Jiaxin Zhang
Shiwei Yang
Kunpeng Li
Jian Zhu
Jianglin Zhang
Yinghua Liu
Feng Huang
author_facet Jiawen Hu
Yiwen Wang
Zhimeng Yu
Yinan Zhang
Xiaojian Ji
Lulu Zeng
Jiaxin Zhang
Shiwei Yang
Kunpeng Li
Jian Zhu
Jianglin Zhang
Yinghua Liu
Feng Huang
author_sort Jiawen Hu
collection DOAJ
description Background: Ankylosing spondylitis (AS) is a progressive chronic disease that primarily affects the axial skeleton, leading to significant musculoskeletal impairment. This condition may extend its inflammatory impact to peripheral muscles, potentially resulting in muscle wasting. Objectives: The study aimed to investigate the prevalence of sarcopenia among AS patients, to determine the specific cutoff values for muscle status, and to identify risk factors that may impact muscle status in AS patients. Design: A cross-sectional study was conducted involving consecutive AS patients attending the Department of Rheumatology and Immunology at the First Medical Center of the Chinese PLA General Hospital. Clinical characteristics and body composition were evaluated. Methods: Based on the Asian Working Group for Sarcopenia criteria, the prevalence of sarcopenia among AS patients were calculated. Additionally, specific cutoff values for muscle mass and muscle strength in AS patients were analyzed. Univariable and multivariable logistic regression analyses were employed to scrutinize risk factors impacting muscle status in AS patients, including appendicular skeletal muscle mass index (ASMI) and grip strength. Results: Measurements of body composition, including ASM at 22.79 kg and ASMI at 7.69 kg/m², were significantly lower compared to the healthy control group ( p  < 0.05). The prevalence of sarcopenia, as identified by the sex-specific fifth percentile, is 8.66% in AS patients. In our study, the ASMI cutoffs were set at 7.48 kg/m² for males and 5.63 kg/m² for females. Logistic regression analysis revealed that AS patients who had a longer disease duration, lower level of education, elevated inflammatory markers, and a higher Bath Ankylosing Spondylitis Metrology Index (BASMI) were more likely to experience a decrease in ASMI. Regarding the muscle strength, lower education level and higher Bath Ankylosing Spondylitis Functional Index were correlated with a reduced grip strength in individuals with AS. Conclusion: Our study indicates that AS patients may have a diminished muscle status. Although the incidence of sarcopenia among AS patients is relatively low, a notable subset does suffer from muscle atrophy. Variables such as disease duration, education level, inflammatory markers, and BASMI are likely to influence muscle status in AS patients, warranting consideration in clinical management and intervention strategies.
format Article
id doaj-art-a71fe03b58ae4802a82aad9167ef5d95
institution DOAJ
issn 1759-7218
language English
publishDate 2025-05-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Musculoskeletal Disease
spelling doaj-art-a71fe03b58ae4802a82aad9167ef5d952025-08-20T02:58:01ZengSAGE PublishingTherapeutic Advances in Musculoskeletal Disease1759-72182025-05-011710.1177/1759720X251335591Muscle health in ankylosing spondylitis: effects of disease duration, inflammation, education level, and spinal mobility on skeletal muscle atrophyJiawen HuYiwen WangZhimeng YuYinan ZhangXiaojian JiLulu ZengJiaxin ZhangShiwei YangKunpeng LiJian ZhuJianglin ZhangYinghua LiuFeng HuangBackground: Ankylosing spondylitis (AS) is a progressive chronic disease that primarily affects the axial skeleton, leading to significant musculoskeletal impairment. This condition may extend its inflammatory impact to peripheral muscles, potentially resulting in muscle wasting. Objectives: The study aimed to investigate the prevalence of sarcopenia among AS patients, to determine the specific cutoff values for muscle status, and to identify risk factors that may impact muscle status in AS patients. Design: A cross-sectional study was conducted involving consecutive AS patients attending the Department of Rheumatology and Immunology at the First Medical Center of the Chinese PLA General Hospital. Clinical characteristics and body composition were evaluated. Methods: Based on the Asian Working Group for Sarcopenia criteria, the prevalence of sarcopenia among AS patients were calculated. Additionally, specific cutoff values for muscle mass and muscle strength in AS patients were analyzed. Univariable and multivariable logistic regression analyses were employed to scrutinize risk factors impacting muscle status in AS patients, including appendicular skeletal muscle mass index (ASMI) and grip strength. Results: Measurements of body composition, including ASM at 22.79 kg and ASMI at 7.69 kg/m², were significantly lower compared to the healthy control group ( p  < 0.05). The prevalence of sarcopenia, as identified by the sex-specific fifth percentile, is 8.66% in AS patients. In our study, the ASMI cutoffs were set at 7.48 kg/m² for males and 5.63 kg/m² for females. Logistic regression analysis revealed that AS patients who had a longer disease duration, lower level of education, elevated inflammatory markers, and a higher Bath Ankylosing Spondylitis Metrology Index (BASMI) were more likely to experience a decrease in ASMI. Regarding the muscle strength, lower education level and higher Bath Ankylosing Spondylitis Functional Index were correlated with a reduced grip strength in individuals with AS. Conclusion: Our study indicates that AS patients may have a diminished muscle status. Although the incidence of sarcopenia among AS patients is relatively low, a notable subset does suffer from muscle atrophy. Variables such as disease duration, education level, inflammatory markers, and BASMI are likely to influence muscle status in AS patients, warranting consideration in clinical management and intervention strategies.https://doi.org/10.1177/1759720X251335591
spellingShingle Jiawen Hu
Yiwen Wang
Zhimeng Yu
Yinan Zhang
Xiaojian Ji
Lulu Zeng
Jiaxin Zhang
Shiwei Yang
Kunpeng Li
Jian Zhu
Jianglin Zhang
Yinghua Liu
Feng Huang
Muscle health in ankylosing spondylitis: effects of disease duration, inflammation, education level, and spinal mobility on skeletal muscle atrophy
Therapeutic Advances in Musculoskeletal Disease
title Muscle health in ankylosing spondylitis: effects of disease duration, inflammation, education level, and spinal mobility on skeletal muscle atrophy
title_full Muscle health in ankylosing spondylitis: effects of disease duration, inflammation, education level, and spinal mobility on skeletal muscle atrophy
title_fullStr Muscle health in ankylosing spondylitis: effects of disease duration, inflammation, education level, and spinal mobility on skeletal muscle atrophy
title_full_unstemmed Muscle health in ankylosing spondylitis: effects of disease duration, inflammation, education level, and spinal mobility on skeletal muscle atrophy
title_short Muscle health in ankylosing spondylitis: effects of disease duration, inflammation, education level, and spinal mobility on skeletal muscle atrophy
title_sort muscle health in ankylosing spondylitis effects of disease duration inflammation education level and spinal mobility on skeletal muscle atrophy
url https://doi.org/10.1177/1759720X251335591
work_keys_str_mv AT jiawenhu musclehealthinankylosingspondylitiseffectsofdiseasedurationinflammationeducationlevelandspinalmobilityonskeletalmuscleatrophy
AT yiwenwang musclehealthinankylosingspondylitiseffectsofdiseasedurationinflammationeducationlevelandspinalmobilityonskeletalmuscleatrophy
AT zhimengyu musclehealthinankylosingspondylitiseffectsofdiseasedurationinflammationeducationlevelandspinalmobilityonskeletalmuscleatrophy
AT yinanzhang musclehealthinankylosingspondylitiseffectsofdiseasedurationinflammationeducationlevelandspinalmobilityonskeletalmuscleatrophy
AT xiaojianji musclehealthinankylosingspondylitiseffectsofdiseasedurationinflammationeducationlevelandspinalmobilityonskeletalmuscleatrophy
AT luluzeng musclehealthinankylosingspondylitiseffectsofdiseasedurationinflammationeducationlevelandspinalmobilityonskeletalmuscleatrophy
AT jiaxinzhang musclehealthinankylosingspondylitiseffectsofdiseasedurationinflammationeducationlevelandspinalmobilityonskeletalmuscleatrophy
AT shiweiyang musclehealthinankylosingspondylitiseffectsofdiseasedurationinflammationeducationlevelandspinalmobilityonskeletalmuscleatrophy
AT kunpengli musclehealthinankylosingspondylitiseffectsofdiseasedurationinflammationeducationlevelandspinalmobilityonskeletalmuscleatrophy
AT jianzhu musclehealthinankylosingspondylitiseffectsofdiseasedurationinflammationeducationlevelandspinalmobilityonskeletalmuscleatrophy
AT jianglinzhang musclehealthinankylosingspondylitiseffectsofdiseasedurationinflammationeducationlevelandspinalmobilityonskeletalmuscleatrophy
AT yinghualiu musclehealthinankylosingspondylitiseffectsofdiseasedurationinflammationeducationlevelandspinalmobilityonskeletalmuscleatrophy
AT fenghuang musclehealthinankylosingspondylitiseffectsofdiseasedurationinflammationeducationlevelandspinalmobilityonskeletalmuscleatrophy